MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
*Architects: Pulmonology (Health IT, Devices & Technology)
Galvanize Therapeutics
Organization & Developments: Galvanize Therapeutics
Parents
Galvanize Therapeutics
Children
*CEO Godshall has chaired the Galvanize board since 2021. In 2024, he led the $13.1 billion sale of Shockwave to Johnson & Johnson MedTech, which is now poised to become the world’s largest medical device company thanks in large part to growth from Shockwave’s intravascular lithotripsy platform.
*Chronic bronchitis symptoms, cardiac arrhythmias and solid tumors
*Energy-based medical device technology that utilizes short-duration and high-voltage electrical pulses to create an electric field that destabilizes cells through multiple biochemical processes
*Galvanize has developed ablation systems that generate and deliver short-duration, high-voltage energy to create electrical fields that kill cells via electroporation while sparing nearby nerves and other structure
*Pulsed-field energy is the nonthermal, minimally invasive technology behind the rush of pulsed-field ablation (PFA) systems for treating atrial fibrillation.
2022: From three companies to one — Galvanize Therapeutics gets $100M to push electric field therapy
2025: Former Shockwave CEO takes over at pulsed electric field company Galvanize Therapeutics with $100M raise
2025: Galvanize aims its pulsed electric fields at cancer
2025: Oncology is the next target, with technologies in the pipeline for lung cancer, hepatocellular cancer (the most common liver cancer), renal cell carcinoma (the most common kidney cancer) and breast cancer.
The newly merged company will be working to develop electric field therapy in the same three areas that the three old companies worked on separately, but now under one platform called Aliya
Jumps
Finance & Acquisitions: Galvanize Therapeutics
Key People: Galvanize Therapeutics